Tbo-Filgrastim

GRANIX

Leukocyte Growth Factor

NADAC/unit N/A

No Shortage Tier 1: 4.6% PA Req: 49.2%

Tbo-Filgrastim stimulates white blood cell production, used to prevent infections during chemotherapy.

Covered Lives

Active Shortages

2025-06-13 Shortage reported, Teva Pharmaceuticals USA, Inc.

Market Intelligence

2025-02-12 Class II Recall: Teva Pharmaceuticals USA, Inc

Explore in the Ecosystem

rxsaver.aiCompare prices for Tbo-Filgrastim drfinder.aiFind doctors who prescribe Tbo-Filgrastim rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Tbo-Filgrastim

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.